Event

Management strategies of pulmonary arterial hypertension (PAH) continue to evolve. Currently, management guidelines recommend risk assessment as a critical component to drive treatment decision-making and comprehensive care for patients with PAH. This interactive, case-based symposium will feature a panel of experts who will discuss the importance of risk assessment in PAH. Dinner will be provided. Dinner will not be provided to physicians and other healthcare professionals licensed in Vermont or other states where gifts and meals are prohibited. A non-CME educational program sponsored by Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceuticals Company of Johnson & Johnson, open to all ATS 2018 International Conference attendees.